Literature DB >> 17963039

11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.

Karen E Chapman1, Jonathan R Seckl.   

Abstract

11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) is an intracellular amplifier of glucocorticoid action. By converting intrinsically inert glucocorticoids (cortisone, 11-dehydrocorticosterone) into their active forms (cortisol, corticosterone), 11beta-HSD1 increases glucocorticoid access to receptors. Glucocorticoid hormones modulate diverse physiological processes, linking circadian rhythms to food seeking, motivational and cognitive behaviours, as well as intermediary metabolism and immune responses. They are a key component of pathways that buffer the organism against stressful challenges. Here we review the part played in these processes by 11beta-HSD1, and discuss the promise of inhibitors of 11beta-HSD1 in alleviating disorders associated with cumulative stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963039     DOI: 10.1007/s11064-007-9504-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  182 in total

1.  Differential expression of multiple unexpected genes during U937 cell and macrophage differentiation detected by suppressive subtractive hybridization.

Authors:  M C Gingras; J F Margolin
Journal:  Exp Hematol       Date:  2000-01       Impact factor: 3.084

2.  Inactivation of the GR in the nervous system affects energy accumulation.

Authors:  Christoph Kellendonk; Sandra Eiden; Oliver Kretz; Günther Schütz; Ingrid Schmidt; François Tronche; Eckhart Simon
Journal:  Endocrinology       Date:  2002-06       Impact factor: 4.736

3.  Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system?

Authors:  Martin Schmidt; Claudia Weidler; Heidrun Naumann; Sven Anders; Jürgen Schölmerich; Rainer H Straub
Journal:  Arthritis Rheum       Date:  2005-06

Review 4.  Stress and the aging hippocampus.

Authors:  B S McEwen
Journal:  Front Neuroendocrinol       Date:  1999-01       Impact factor: 8.606

Review 5.  Adrenal steroid receptors and actions in the nervous system.

Authors:  B S McEwen; E R De Kloet; W Rostene
Journal:  Physiol Rev       Date:  1986-10       Impact factor: 37.312

6.  The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities.

Authors:  Tian Y Zhang; Xiaohong Ding; Raymond A Daynes
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

Review 7.  Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.

Authors:  J R Seckl; M Cleasby; M J Nyirenda
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

Review 8.  Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.

Authors:  Hiroaki Masuzaki; Jeffrey S Flier
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

9.  Deficits in hippocampus-mediated Pavlovian conditioning in endogenous hypercortisolism.

Authors:  Christian Grillon; Kathryn Smith; Ann Haynos; Lynnette K Nieman
Journal:  Biol Psychiatry       Date:  2004-12-01       Impact factor: 13.382

10.  Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.

Authors:  T Mune; F M Rogerson; H Nikkilä; A K Agarwal; P C White
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

View more
  12 in total

1.  11beta-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments.

Authors:  Megan C Holmes; Roderick N Carter; June Noble; Shruti Chitnis; Amy Dutia; Janice M Paterson; John J Mullins; Jonathan R Seckl; Joyce L W Yau
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

Review 2.  HPA axis responsiveness to stress: implications for healthy aging.

Authors:  Greti Aguilera
Journal:  Exp Gerontol       Date:  2010-09-09       Impact factor: 4.032

3.  Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia.

Authors:  Ananda Chapagain; Paul W Caton; Julius Kieswich; Petros Andrikopoulos; Nanda Nayuni; Jamie H Long; Steven M Harwood; Scott P Webster; Martin J Raftery; Christoph Thiemermann; Brian R Walker; Jonathan R Seckl; Roger Corder; Muhammad Magdi Yaqoob
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-25       Impact factor: 11.205

Review 4.  Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics.

Authors:  Andrea H Marques; Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

5.  Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet.

Authors:  Z Michailidou; R N Carter; E Marshall; H G Sutherland; D G Brownstein; E Owen; K Cockett; V Kelly; L Ramage; E A S Al-Dujaili; M Ross; I Maraki; K Newton; M C Holmes; J R Seckl; N M Morton; C J Kenyon; K E Chapman
Journal:  FASEB J       Date:  2008-08-12       Impact factor: 5.191

6.  Dexamethasone-induced selenoprotein S degradation is required for adipogenesis.

Authors:  Choon Young Kim; Kee-Hong Kim
Journal:  J Lipid Res       Date:  2013-05-18       Impact factor: 5.922

7.  Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.

Authors:  Yanjun Liu; Yuichi Nakagawa; Ying Wang; Limei Liu; Hongwei Du; Wei Wang; Xiuhai Ren; Kabirullah Lutfy; Theodore C Friedman
Journal:  J Mol Endocrinol       Date:  2008-06-04       Impact factor: 5.098

8.  Central glucocorticoid administration promotes weight gain and increased 11β-hydroxysteroid dehydrogenase type 1 expression in white adipose tissue.

Authors:  Christelle Veyrat-Durebex; Nicolas Deblon; Aurélie Caillon; Ruth Andrew; Jordi Altirriba; Alex Odermatt; Françoise Rohner-Jeanrenaud
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

Review 9.  Modulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammation.

Authors:  Patrick W F Hadoke; Tiina Kipari; Jonathan R Seckl; Karen E Chapman
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

10.  Mast cells express 11β-hydroxysteroid dehydrogenase type 1: a role in restraining mast cell degranulation.

Authors:  Agnes E Coutinho; Jeremy K Brown; Fu Yang; David G Brownstein; Mohini Gray; Jonathan R Seckl; John S Savill; Karen E Chapman
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.